Dillon & Associates Inc Abb Vie Inc. Transaction History

Dillon & Associates Inc

$637 Million
Q1 2024

A detailed history of Dillon & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Dillon & Associates Inc holds 6,862 shares of ABBV stock, worth $1.15 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

6,862

Previous 6,661 3.02%

Holding current value

$1.15 Million

Previous $1.03 Million 21.03%

% of portfolio

0.2%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $32,123 - $36,602	201 Added 3.02%	6,862 $1.25 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $29,256 - $33,868	219 Added 3.4%	6,661 $992,000
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $47,836 - $59,528	-361 Reduced 5.31%	6,442 $870,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $840,617 - $968,097	-5,813 Reduced 46.08%	6,803 $1.08 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $563,545 - $649,006	3,897 Added 44.7%	12,616 $2.01 Million

Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $152,832 - $183,286	-1,105 Reduced 11.25%	8,719 $1.41 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $26,842 - $30,786	-200 Reduced 2.0%	9,824 $1.32 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $13,762 - $17,496	-100 Reduced 0.99%	10,024 $1.53 Million
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $328,894 - $408,065	-2,492 Reduced 19.75%	10,124 $1.64 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $18,585 - $23,515	-173 Reduced 1.35%	12,616 $1.7 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $425 - $483	4 Added 0.03%	12,789 $1.38 Million
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 0.78%	12,785 $1.45 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $334,827 - $368,605	-3,273 Reduced 20.26%	12,885 $1.39 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $8,762 - $10,284	102 Added 0.64%	16,158 $1.42 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $5,502 - $7,363	-75 Reduced 0.46%	16,056 $1.57 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $228,007 - $345,687	-3,535 Reduced 17.98%	16,131 $1.23 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $48,687 - $60,918	-675 Reduced 3.32%	19,666 $1.75 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $143,279 - $172,263	-2,275 Reduced 10.06%	20,341 $1.55 Million
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $1.77 Million - $2.26 Million	-26,930 Reduced 54.35%	22,616 $1.65 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $4.61 Million - $5.43 Million	-59,786 Reduced 54.68%	49,546 $4.01 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $198,595 - $244,921	-2,551 Reduced 2.28%	109,332 $10.1 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $231,166 - $256,984	-2,600 Reduced 2.27%	111,883 $10.6 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $303,187 - $358,738	-3,377 Reduced 2.87%	114,483 $10.6 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $299,584 - $401,171	-3,256 Reduced 2.69%	117,860 $11.2 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $78,185 - $85,737	-873 Reduced 0.72%	121,116 $11.7 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $77,044 - $98,409	-1,103 Reduced 0.9%	121,989 $10.9 Million
Q2 2017 Aug 09, 2017	BUY	N/A	123,092	123,092 $8.99 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account

Dillon & Associates Inc Abb Vie Inc. Transaction History